Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1833 of 6351
-
New pill could tame rare hormone disorder
Disease control CompletedThe purpose of this Phase 2, open-label, sequential dose cohort study is to evaluate the safety, efficacy, and pharmacokinetics (PK) of atumelnant (CRN04894) in participants with classic congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency.
Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New anxiety drug shows promise in early trial
Symptom relief CompletedThe ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)
Phase 2 • Sponsor: Engrail Therapeutics INC • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New hope for kids with rare nerve disease: drug trial launches
Disease control Recruiting nowA Phase 2, open-label, multicenter study to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), and safety of inebilizumab in eligible pediatric participants 2 to \< 18 years of age with recently active neuromyelitis optica spectrum disorder (NMOSD) who are seropositive fo…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Exercise after breast cancer: a new prescription for survival?
Disease control Recruiting nowThis is a 24-week exercise programme consisting of aerobic exercise and muscle strength training, 3 sessions per week. The first 9 sessions are supervised by physiotherapists in person, followed by 63 sessions monitored remotely (video) or supervised by trainers at ActiveSG (Spor…
Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 26, 2026 13:45 UTC
-
Brain training may boost memory after concussion, study suggests
Symptom relief OngoingThe proposed study tests the efficacy (Phase II) of 36 or 54 30-minute training sessions of PATH neurotraining followed by digit memory exercises to improve working memory, processing speed and attention in mTBI patients rapidly and effectively to provide clinical testing of a th…
Sponsor: Perception Dynamics Institute • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Talking therapy may lower heart risk in PTSD patients
Symptom relief Recruiting nowThis is a pilot randomized controlled trial to assess the impact of a first-line treatment for posttraumatic stress disorder (PTSD) (Cognitive Processing Therapy; CPT) versus waitlist control on mechanisms of cardiovascular disease (CVD) risk. Further, this study will test the hy…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Engineered immune cells take on Drug-Resistant lung cancer in first human trial
Disease control Recruiting nowThis study assesses the safety and efficacy of NK510 combined with PD-(L)1 inhibitors for relapsed/refractory advanced NSCLC, with two administration routes: intravenous infusion and intrapleural perfusion for malignant pleural effusion. Eligible patients need confirmed measurabl…
Early phase 1 • Sponsor: Base Therapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Heart attack drug shows promise in reducing damage
Disease control CompletedThis Randomized controlled intervention study recruited patients diagnosed with ST-segment elevation myocardial infarction (STEMI). A total of 240 patients were enrolled in either Henagliflozin group or control group. Patients in Henggliflozin group will be given by oral administ…
Phase 4 • Sponsor: Qian geng • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Clot-Busting drugs may cut death risk in lung clot patients
Disease control CompletedThe aim of investigators was to study the effect and safety of Thrombolysis in Intermediate high risk pulmonary embolism patients with low bleeding risk as regards Mortality and bleeding events.
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill targets hormone imbalance from adrenal tumors
Disease control CompletedThis is study with SPI-62 to evaluate the efficacy, safety, and pharmacological effect of SPI-62 in subjects with hypercortisolism related to a benign adrenal tumor. Each subject will receive 2mg of SPI-62 daily.
Phase 2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Magic mushroom mystery: can psilocybin fight depression without the trip?
Knowledge-focused CompletedPsilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. In healthy volunteers, the psychedelic effects of psilocybin have been shown to be bl…
Phase 2 • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Womb microbes under the microscope: could they hold the key to unexplained infertility?
Knowledge-focused Recruiting nowChronic endometritis is an inflammatory condition of the endometrium. This inflammation can negatively affect fertility and pregnancy. The pathology is frequently (+-10%) observed in women with fertility problems. Today, diagnosis of chronic endometritis is not evident, since no …
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Laughter and tai chi: a gentle prescription for frailty?
Disease control CompletedThe goals of this study are to examine the physical function, cognitive function, and quality of life among frail elderly residing in the community
Sponsor: Chungnam National University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can unstable core training paddle kayakers to greater power?
Knowledge-focused CompletedA randomized controlled trial was conducted, recruiting 24 eligible kayakers aged 14-22 years from the Jiangxi training base, China. Participants were randomly assigned to the SUCT group and the DUCT group. Both groups completed a 12-week unstable core training program consisting…
Sponsor: Gao Jianxin • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Refresher training may extend brain benefits for veterans with mild memory issues
Symptom relief By invitation onlyVeterans have numerous risk factors (e.g., Post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), cerebrovascular problems) for later-life cognitive and functional decline. Evidence supports the effectiveness of strategy-based cognitive rehabilitation therapies, inc…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Targeting depression: can MRI-Guided brain zaps rewire key circuits?
Knowledge-focused CompletedThe purpose of this research is to understand how a neurostimulation technique, transcranial electrical stimulation (tES), affects brain function in adults with major depression measured with functional magnetic resonance imaging (fMRI). This study targets a specific kind of tES …
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Shock therapy for stroke hands? new trial tests brain zaps
Symptom relief Recruiting nowAfter a stroke, it is very common to lose the ability to open the affected hand. Occupational and physical rehabilitation therapy (OT and PT) combined with non-invasive brain stimulation may help a person recover hand movement. The purpose of this study is to compare 3 non-invas…
Sponsor: MetroHealth Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Peer mentors may help young adults stick with addiction treatment
Disease control OngoingEmerging adults (ages 18-25) are at higher risk for substance use disorders, including opiate addiction, than any other age group but are also more likely to drop out early from substance use treatment services. This project will evaluate an enhancement to usual services, deliver…
Sponsor: UConn Health • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New tests could transform care for rare kidney diseases
Knowledge-focused OngoingThis protocol is part of a larger project, COMPRare (COMPlement-mediated Rare kidney diseases), which has been financed on behalf of the EJP RD (European Joint Programme on Rare Diseases) program of EU and is leaded by a scientific consortium from 7 European countries. The partn…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Couples program aims to keep young HIV-positive women in care by tackling alcohol and abuse
Disease control By invitation onlyThis study will develop and pilot test a couples-based intervention to help adolescent girls and young women living with HIV (WLHIV (15-24 years) living in Uganda access HIV care and improve the outcomes of their HIV treatment by targeting male partner alcohol use to reduce IPV r…
Sponsor: Arizona State University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC